Table: Fuso Pharmaceutical -2016/17 parent results

Fuso Pharmaceutical Industries

11/05/2017 05:40

May 11 (Reuters)-  
          Fuso Pharmaceutical Industries Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           46.78           45.75          47.30        23.60     
               (+2.2 pct)      (-2.7 pct)     (+1.1 pct)    (-0.5 pct)  
  Operating      656 mln         296 mln        800 mln      200 mln    
              (+121.2 pct)     (-62.8 pct)    (+21.9 pct)  (-54.1 pct)  
  Recurring      642 mln         172 mln        800 mln      200 mln    
              (+272.4 pct)     (-74.6 pct)    (+24.6 pct)  (-61.1 pct)  
  Net            861 mln         10 mln         600 mln      150 mln    
                               (-97.0 pct)    (-30.3 pct)  (-63.1 pct)  
  EPS           95.86 yen       1.12 yen       66.78 yen    16.69 yen   
  Ann Div                       8.00 yen       80.00 yen                
  -Q2 Div       4.00 yen        4.00 yen       40.00 yen                
  -Q4 Div       40.00 yen       4.00 yen       40.00 yen                
   
  NOTE - Fuso Pharmaceutical Industries Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T  
  ((Tokyo Headline News Desk +813 6441 1812))